Skip to Main Content

Paper Details

Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial.
Am Heart J
27
2016
Author NameAffiliation
Charles V PollackThomas Jefferson University
  • 1 - 1

Datasets

Release 1.2